7 December 2015 - Deborah Wilkes
Archived
Almirall is strengthening its presence in dermatology by acquiring Poli Group in a deal worth €365 million (US$395 million) plus potential additional earn-out payments. The Spanish company said the transaction would reinforce "significantly" its OTC presence in Germany, where Poli Group owns Taurus Pharma.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.